AMLODIPINE BESYLATE VALSARTAN HYDROCHLOROTHIAZIDE

AMLODIPINE BESYLATE VALSARTAN HYDROCHLOROTHIAZIDE was reported 41 times

These side effects are most commonly reported by patients taking AMLODIPINE BESYLATE VALSARTAN HYDROCHLOROTHIAZIDE:

# Side effect Count
0 BASAL CELL CARCINOMA 2
1 BLOOD TRIGLYCERIDES INCREASED 2
2 BRONCHITIS 2
3 CLAUDICATION OF JAW MUSCLES 2
4 COMPLETED SUICIDE 2
5 CONDITION AGGRAVATED 2
6 DEATH 2
7 DEPRESSION 2
8 DRUG INEFFECTIVE 2
9 DRUG INTERACTION 2
10 DYSPHONIA 2
11 EAR NEOPLASM 2
12 EYELID PTOSIS 2
13 FALL 2
14 HEADACHE 2
15 HYPERTENSION 2
16 HYPOREFLEXIA 2
17 ILLNESS 2
18 INFLUENZA 2
19 INTERMITTENT CLAUDICATION 2
20 MYASTHENIA GRAVIS 2
21 NAIL DISORDER 2
22 NASOPHARYNGITIS 2
23 NEOPLASM SKIN 2
24 PNEUMONIA 2
25 PRODUCT CONTAMINATION CHEMICAL 2
26 RASH 2
27 RENAL FAILURE 2
28 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2
29 THROMBOSIS 2
30 ADVERSE DRUG REACTION 1
31 AFFECTIVE DISORDER 1
32 ALOPECIA 1
33 ANKLE FRACTURE 1
34 ANTIBODY TEST POSITIVE 1
35 ASTHMA 1
36 BALANCE DISORDER 1
37 BLINDNESS 1
38 BLOOD CHOLESTEROL INCREASED 1
39 BLOOD GLUCOSE INCREASED 1
40 BLOOD PRESSURE INCREASED 1
41 BODY HEIGHT DECREASED 1
42 BREATH SOUNDS ABNORMAL 1
43 BRONCHIAL DISORDER 1
44 BRONCHIAL HAEMORRHAGE 1
45 BRONCHIAL NEOPLASM 1
46 BURNING SENSATION 1
47 CARDIAC MURMUR 1
48 CATARACT 1
49 CHEST DISCOMFORT 1
50 COUGH 1
51 DEAFNESS 1
52 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1
53 DRUG WITHDRAWAL CONVULSIONS 1
54 DRY EYE 1
55 DRY SKIN 1
56 DYSPNOEA 1
57 ENDOMETRIAL ABLATION 1
58 EPISTAXIS 1
59 EXPOSURE DURING PREGNANCY 1
60 EYE HAEMORRHAGE 1
61 FATIGUE 1
62 FEELING ABNORMAL 1
63 GAIT DISTURBANCE 1
64 GALLBLADDER DISORDER 1
65 GASTRITIS 1
66 GASTROINTESTINAL DISORDER 1
67 GLYCOSYLATED HAEMOGLOBIN INCREASED 1
68 GRANULOMA 1
69 HERPES ZOSTER 1
70 HYPERSENSITIVITY 1
71 HYPOKALAEMIA 1
72 HYPOTENSION 1
73 IMMUNE-MEDIATED MYOSITIS 1
74 INFECTION 1
75 INFECTIOUS PLEURAL EFFUSION 1
76 INFLUENZA LIKE ILLNESS 1
77 INJECTION SITE PAIN 1
78 INJECTION SITE REACTION 1
79 INJECTION SITE SWELLING 1
80 JOINT SWELLING 1
81 KIDNEY INFECTION 1
82 LOW DENSITY LIPOPROTEIN INCREASED 1
83 LOWER RESPIRATORY TRACT INFECTION 1
84 LUNG NEOPLASM MALIGNANT 1
85 MALAISE 1
86 MALIGNANT MELANOMA 1
87 MATERNAL EXPOSURE DURING PREGNANCY 1
88 MEMORY IMPAIRMENT 1
89 NASAL CONGESTION 1
90 NASAL TURBINATE HYPERTROPHY 1
91 NEPHROPATHY TOXIC 1
92 OBSTRUCTIVE AIRWAYS DISORDER 1
93 OCULAR HYPERAEMIA 1
94 OEDEMA 1
95 OEDEMA PERIPHERAL 1
96 OSTEOPOROSIS 1
97 OXYGEN SATURATION DECREASED 1
98 PAIN 1
99 PERIPHERAL SWELLING 1
100 PHARYNGITIS 1
101 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 1
102 PRODUCT ADMINISTRATION INTERRUPTED 1
103 PRODUCT DOSE OMISSION ISSUE 1
104 PRODUCT PRESCRIBING ERROR 1
105 PRODUCT USE ISSUE 1
106 PRURITUS 1
107 RECALLED PRODUCT 1
108 RECALLED PRODUCT ADMINISTERED 1
109 RESPIRATORY DISORDER 1
110 RHINITIS 1
111 RHONCHI 1
112 SINUS TACHYCARDIA 1
113 SINUSITIS 1
114 SKIN EXFOLIATION 1
115 SKIN FISSURES 1
116 SOMNOLENCE 1
117 SPINAL PAIN 1
118 SUBGALEAL HAEMATOMA 1
119 SYNCOPE 1
120 TRANSIENT ISCHAEMIC ATTACK 1
121 TUMOUR HAEMORRHAGE 1
122 UPPER LIMB FRACTURE 1
123 URINARY TRACT INFECTION 1
124 VERTIGO 1
125 VISUAL IMPAIRMENT 1
126 WEIGHT INCREASED 1
127 WHEEZING 1